These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 24503893
1. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Kim M, Hunter RW, Garcia-Menendez L, Gong G, Yang YY, Kolwicz SC, Xu J, Sakamoto K, Wang W, Tian R. Circ Res; 2014 Mar 14; 114(6):966-75. PubMed ID: 24503893 [Abstract] [Full Text] [Related]
2. A novel, de novo mutation in the PRKAG2 gene: infantile-onset phenotype and the signaling pathway involved. Xu Y, Gray A, Hardie DG, Uzun A, Shaw S, Padbury J, Phornphutkul C, Tseng YT. Am J Physiol Heart Circ Physiol; 2017 Aug 01; 313(2):H283-H292. PubMed ID: 28550180 [Abstract] [Full Text] [Related]
4. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, Li GH, Burgon PG, Maguire CT, Stapleton D, Schmitt JP, Guo XX, Pizard A, Kupershmidt S, Roden DM, Berul CI, Seidman CE, Seidman JG. Circulation; 2003 Jun 10; 107(22):2850-6. PubMed ID: 12782567 [Abstract] [Full Text] [Related]
5. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. N Engl J Med; 2005 Jan 27; 352(4):362-72. PubMed ID: 15673802 [Abstract] [Full Text] [Related]
6. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R. J Clin Invest; 2007 May 27; 117(5):1432-9. PubMed ID: 17431505 [Abstract] [Full Text] [Related]
7. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Ahmad F, Arad M, Musi N, He H, Wolf C, Branco D, Perez-Atayde AR, Stapleton D, Bali D, Xing Y, Tian R, Goodyear LJ, Berul CI, Ingwall JS, Seidman CE, Seidman JG. Circulation; 2005 Nov 15; 112(20):3140-8. PubMed ID: 16275868 [Abstract] [Full Text] [Related]
8. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway. Zhang BL, Xu RL, Zhang J, Zhao XX, Wu H, Ma LP, Hu JQ, Zhang JL, Ye Z, Zheng X, Qin YW. J Cardiol; 2013 Oct 15; 62(4):241-8. PubMed ID: 23778007 [Abstract] [Full Text] [Related]
10. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Akman HO, Sampayo JN, Ross FA, Scott JW, Wilson G, Benson L, Bruno C, Shanske S, Hardie DG, Dimauro S. Pediatr Res; 2007 Oct 15; 62(4):499-504. PubMed ID: 17667862 [Abstract] [Full Text] [Related]
12. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. Hinson JT, Chopra A, Lowe A, Sheng CC, Gupta RM, Kuppusamy R, O'Sullivan J, Rowe G, Wakimoto H, Gorham J, Burke MA, Zhang K, Musunuru K, Gerszten RE, Wu SM, Chen CS, Seidman JG, Seidman CE. Cell Rep; 2016 Dec 20; 17(12):3292-3304. PubMed ID: 28009297 [Abstract] [Full Text] [Related]
13. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Burwinkel B, Scott JW, Bührer C, van Landeghem FK, Cox GF, Wilson CJ, Grahame Hardie D, Kilimann MW. Am J Hum Genet; 2005 Jun 20; 76(6):1034-49. PubMed ID: 15877279 [Abstract] [Full Text] [Related]
14. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells. Zhan Y, Sun X, Li B, Cai H, Xu C, Liang Q, Lu C, Qian R, Chen S, Yin L, Sheng W, Huang G, Sun A, Ge J, Sun N. J Mol Cell Cardiol; 2018 Apr 20; 117():49-61. PubMed ID: 29452156 [Abstract] [Full Text] [Related]
15. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen. Folmes KD, Chan AY, Koonen DP, Pulinilkunnil TC, Baczkó I, Hunter BE, Thorn S, Allard MF, Roberts R, Gollob MH, Light PE, Dyck JR. Circ Cardiovasc Genet; 2009 Oct 20; 2(5):457-66. PubMed ID: 20031621 [Abstract] [Full Text] [Related]
16. Myostatin regulates energy homeostasis in the heart and prevents heart failure. Biesemann N, Mendler L, Wietelmann A, Hermann S, Schäfers M, Krüger M, Boettger T, Borchardt T, Braun T. Circ Res; 2014 Jul 07; 115(2):296-310. PubMed ID: 24807786 [Abstract] [Full Text] [Related]
17. [AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage]. Ofir M, Hochhauser E, Vidne BA, Freimark D, Arad M. Harefuah; 2007 Oct 07; 146(10):770-5, 813-4. PubMed ID: 17990392 [Abstract] [Full Text] [Related]
18. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation. Bayrak F, Komurcu-Bayrak E, Mutlu B, Kahveci G, Basaran Y, Erginel-Unaltuna N. Eur J Heart Fail; 2006 Nov 07; 8(7):712-5. PubMed ID: 16716659 [Abstract] [Full Text] [Related]